Skip to content

Research at St Andrews

Novel benzothiazole-based ureas as 17β-HSD10 inhibitors, a potential Alzheimer’s disease treatment

Research output: Contribution to journalArticle

Author(s)

Laura Aitken, Ondrej Benek, Brogan McKelvie, Rebecca E. Hughes, Lukas Hroch, Monika Schmidt, Louise L Major, Lucie Vinklarova, Kamil Kuca, Terry K Smith, Kamil Musilek, Frank J Gunn-Moore

School/Research organisations

Abstract

It has long been established, that mitochondrial dysfunction in Alzheimer’s disease (AD) patients can trigger pathological changes in cell metabolism by altering metabolic enzymes such as the mitochondrial 17β-hydroxysteroid dehydrogenase type 10 (17β-HSD10) also known as amyloid-binding alcohol dehydrogenase (ABAD). We and others have shown that frentizole and riluzole derivatives can inhibit 17β-HSD10 and that this inhibition is beneficial and holds therapeutic merit for the treatment of AD. Here we evaluate several novel series based on benzothiazolylurea scaffold evaluating key structural and activity relationships required for the inhibition of 17β-HSD10. Results show that the most promising of these compounds have markedly increased potency on our previously published inhibitors, with the most promising exhibiting advantageous features like low cytotoxicity and target engagement in living cells.
Close

Details

Original languageEnglish
Article number2757
JournalMolecules
Volume24
Issue number15
DOIs
Publication statusPublished - 29 Jul 2019

    Research areas

  • Alzheimer's disease (AD), Amyloid-beta peptide (Aβ), Mitochondria, Amyloid binding alcohol dehydrogenase (ABAD), 17β-Hydroxysteroid dehydrogenase type 10 (17β-HSD10), Benzothiazole

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. In vitro assay development and HTS of small molecule human ABAD/17β-HSD10 inhibitors as therapeutics in Alzheimer’s Disease

    Aitken, L., Baillie, G., Pannifer, A., Morrison, A., Jones, P. S., Smith, T. K., McElroy, S. P. & Gunn-Moore, F. J., Jul 2017, In : SLAS Discovery. 22, 6, p. 676-685 11 p.

    Research output: Contribution to journalArticle

  2. 6-benzothiazolyl ureas, thioureas and guanidines are potent inhibitors of ABAD/17β-HSD10 and potential drugs for Alzheimer's disease treatment: design, synthesis and in vitro evaluation

    Benek, O., Hroch, L., Aitken, L., Dolezal, R., Guest, P., Benkova, M., Soukup, O., Musil, K., Hughes, R., Kuca, K., Smith, T. K., Gunn-Moore, F. & Musilek, K., Jun 2017, In : Medicinal Chemistry. 13, 4, p. 345-358 14 p.

    Research output: Contribution to journalArticle

  3. Synthesis and evaluation of frentizole-based indolyl thiourea analogues as MAO/ABAD inhibitors for Alzheimer’s disease treatment

    Hroch, L., Guest, P., Benek, O., Soukup, O., Janockova, J., Dolezal, R., Kuca, K., Aitken, L., Smith, T. K., Gunn-Moore, F., Zala, D., Ramsay, R. R. & Musilek, K., 1 Feb 2017, In : Bioorganic & Medicinal Chemistry. 25, 3, p. 1143-1152 10 p.

    Research output: Contribution to journalArticle

  4. Design, synthesis and in vitro evaluation of benzothiazole-based ureas as potential ABAD/17β-HSD10 modulators for Alzheimer’s disease treatment

    Hroch, L., Benek, O., Guest, P., Aitken, L., Soukup, O., Janockova, J., Musil, K., Dohnal, V., Dolezal, R., Kuca, K., Smith, T. K., Gunn-Moore, F. J. & Musilek, K., 1 Aug 2016, In : Bioorganic and Medicinal Chemistry Letters. 26, 15, p. 3675-3678 4 p.

    Research output: Contribution to journalLetter

  5. Inhibitors of Trypanosoma cruzi Sir2 related protein 1 as potential drugs against Chagas disease

    Gaspar, L., Coron, R. P., Kongthoo Lin, P., Costa, D. M., Perez-Cabezas, B., Tavares, J., Roura-Ferrer, M., Ramos, I., Ronin, C., Major, L. L., Ciesielski, F., Pemberton, I. K., MacDougall, J., Ciapetti, P., Smith, T. K. & Cordeiro-da-Silva, A., 22 Jan 2018, In : PLoS Neglected Tropical Diseases. 12, 1, 30 p., e0006180.

    Research output: Contribution to journalArticle

Related by journal

  1. Molecules (Journal)

    John Christopher Walton (Member of editorial board)
    10 May 2016

    Activity: Publication peer-review and editorial work typesEditor of research journal

  2. Molecules (Journal)

    John Christopher Walton (Member of editorial board)
    31 Aug 2014

    Activity: Publication peer-review and editorial work typesEditor of research journal

  3. Molecules (Journal)

    John Christopher Walton (Member of editorial board)
    20132018

    Activity: Publication peer-review and editorial work typesEditor of research journal

Related by journal

  1. Halogen and hydrogen bonding in halogenabenzene/NH3 complexes compared using next-generation QTAIM

    Li, S., Xu, T., van Mourik, T., Früchtl, H., Kirk, S. R. & Jenkins, S., 8 Aug 2019, In : Molecules. 24, 16, 12 p., 2875.

    Research output: Contribution to journalArticle

  2. Diverse derivatives of selenoureas: a synthetic and single crystal structural study

    Hua, G., Cordes, D. B., Du, J., Slawin, A. M. Z. & Woollins, J. D., 25 Aug 2018, In : Molecules. 23, 9, 2143.

    Research output: Contribution to journalArticle

  3. Further studies on the pyrolytic domino cyclization of stabilized phosphonium ylides bearing an ortho-aminophenyl group

    Aitken, R. A., Murray, L. & Slawin, A. M. Z., 27 Aug 2018, In : Molecules. 23, 9, 12 p., 2153.

    Research output: Contribution to journalArticle

  4. Microhydration and the enhanced acidity of free radicals

    Walton, J. C., 14 Feb 2018, In : Molecules. 23, 2, 423.

    Research output: Contribution to journalArticle

ID: 260299059